Perceptive Advisors’s Array Biopharma Inc ARRY Stock Holding History

Perceptive Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,038,390	Closed	-$48.1M	–	129
2019 Q2	$48.1M	Sell	1,038,390 -3,190,510	-75%	-$89.6M	1.1%	24
2019 Q1	$103M	Buy	+4,228,900	New	+$88M	2.91%	9
2018 Q3	–	Sell	-40,133	Closed	-$673K	–	148
2018 Q2	$673K	Hold	40,133	–	–	0.02%	102
2018 Q1	$655K	Buy	+40,133	New	+$643K	0.02%	117
2017 Q2	–	Sell	-25,510	Closed	-$228K	–	183
2017 Q1	$228K	Buy	+25,510	New	+$271K	0.01%	134
2013 Q4	–	Sell	-572,870	Closed	-$3.56M	–	140
2013 Q3	$3.56M	Buy	572,870 +553,550	+2,865%	+$3.29M	0.29%	45
2013 Q2	$88K	Buy	+19,320	New	+$104K	0.01%	72

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Perceptive Advisors's ARRY Position: Q3 2019 in Review

Perceptive Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,038,390 shares — an estimated $48.1M sold.

Perceptive Advisors first reported a position in ARRY in Q2 2013 and held it in 7 quarters. The position peaked at $103M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Perceptive Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Perceptive Advisors sold 1,038,390 Array Biopharma Inc shares in Q3 2019, an estimated $48.1M.
Perceptive Advisors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 7 quarters.
Perceptive Advisors's Array Biopharma Inc position peaked at $103M in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Perceptive Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.